-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $283

Benzinga·07/28/2026 11:05:25
语音播报
Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $242 to $283.